Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis
•Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle...
Gespeichert in:
Veröffentlicht in: | The Journal of steroid biochemistry and molecular biology 2015-06, Vol.150, p.86-96 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 96 |
---|---|
container_issue | |
container_start_page | 86 |
container_title | The Journal of steroid biochemistry and molecular biology |
container_volume | 150 |
creator | Hengevoss, Jonas Piechotta, Marion Müller, Dennis Hanft, Fabian Parr, Maria Kristina Schänzer, Wilhelm Diel, Patrick |
description | •Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle mass in intact male rats.
Analysing effects of pharmaceutical substances and training on feedback mechanisms of the hypothalamic–pituitary–gonadal axis may be helpful to quantify the benefit of strategies preventing loss of muscle mass, and in the fight against doping. In this study we analysed combined effects of anabolic steroids and training on the hypothalamic–pituitary–gonadal axis. Therefore intact male Wistar rats were dose-dependently treated with metandienone, estradienedione and the selective androgen receptor modulator (SARM) S-1. In serum cortisol, testosterone, 17β-estradiol (E2), prolactin, inhibin B, follicle-stimulating hormone (FSH), luteinizing hormone (LH), Insulin-like growth factor 1 (IGF-1), and thyroxine (T4) concentrations were determined. Six human volunteers were single treated with 1-androstenedione. In addition abusing and clean body builders were analysed. Serum concentrations of inhibin B, IGF-1, cortisol, prolactin, T4, thyroid-stimulating hormone (TSH), testosterone and LH were determined. In rats, administration of metandienone, estradienedione and S-1 resulted in an increase of muscle fiber diameter. Metandienone and estradienedione but not S-1 administration significantly decreases LH and inhibin B serum concentration. Administration of estradienedione resulted in an increase of E2 and S-1 in an increase of cortisol. Single administration of 1-androstenedione in humans decreased cortisol and inhibin B serum concentrations. LH was not affected. In abusing body builders a significantly decrease of LH, TSH and inhibin B and an increase of prolactin, IGF-1 and T4 was detected. In clean body builders only T4 and TSH were affected. |
doi_str_mv | 10.1016/j.jsbmb.2015.03.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1680194874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960076015000886</els_id><sourcerecordid>1680194874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-1366f0172e7d70b32fbec86d746a69882ce08398d559fec9027325b0a052ad8a3</originalsourceid><addsrcrecordid>eNp9kL2O1DAQgC0E4vYWngAJuaRJGNsb2yko0OrgkE6igdpy7MmtV0kcYu-J7XgH3pAnwWEPSqoZab75-wh5xaBmwOTbY31M3djVHFhTg6gBxBOyYVq1FeMcnpINtBIqUBKuyHVKRyiEYOo5ueKNapVQzYakfRy7MKGn2PfocqKxp3byS7zHqSS2i0NwNGVcYvBpLdH5cE7B2YFal8NDyGcaJ5oPSA_nOeaDHewY3K8fP-eQTyHb5Vzy-zhZv7Z8D-kFedbbIeHLx7glXz_cfNnfVnefP37av7-rnGjaXDEhZQ9McVReQSd436HT0qudtLLVmjsELVrtm6Ytp7fAleBNBxYabr22YkveXObOS_x2wpTNGJLDYbATxlMyTGpg7U6rXUHFBXVLTGnB3sxLGMvphoFZbZuj-WPbrLYNCLO63JLXjwtO3Yj-X89fvQV4dwGwvPkQcDHJBZwc-rAU2cbH8N8FvwG_9JVP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680194874</pqid></control><display><type>article</type><title>Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hengevoss, Jonas ; Piechotta, Marion ; Müller, Dennis ; Hanft, Fabian ; Parr, Maria Kristina ; Schänzer, Wilhelm ; Diel, Patrick</creator><creatorcontrib>Hengevoss, Jonas ; Piechotta, Marion ; Müller, Dennis ; Hanft, Fabian ; Parr, Maria Kristina ; Schänzer, Wilhelm ; Diel, Patrick</creatorcontrib><description>•Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle mass in intact male rats.
Analysing effects of pharmaceutical substances and training on feedback mechanisms of the hypothalamic–pituitary–gonadal axis may be helpful to quantify the benefit of strategies preventing loss of muscle mass, and in the fight against doping. In this study we analysed combined effects of anabolic steroids and training on the hypothalamic–pituitary–gonadal axis. Therefore intact male Wistar rats were dose-dependently treated with metandienone, estradienedione and the selective androgen receptor modulator (SARM) S-1. In serum cortisol, testosterone, 17β-estradiol (E2), prolactin, inhibin B, follicle-stimulating hormone (FSH), luteinizing hormone (LH), Insulin-like growth factor 1 (IGF-1), and thyroxine (T4) concentrations were determined. Six human volunteers were single treated with 1-androstenedione. In addition abusing and clean body builders were analysed. Serum concentrations of inhibin B, IGF-1, cortisol, prolactin, T4, thyroid-stimulating hormone (TSH), testosterone and LH were determined. In rats, administration of metandienone, estradienedione and S-1 resulted in an increase of muscle fiber diameter. Metandienone and estradienedione but not S-1 administration significantly decreases LH and inhibin B serum concentration. Administration of estradienedione resulted in an increase of E2 and S-1 in an increase of cortisol. Single administration of 1-androstenedione in humans decreased cortisol and inhibin B serum concentrations. LH was not affected. In abusing body builders a significantly decrease of LH, TSH and inhibin B and an increase of prolactin, IGF-1 and T4 was detected. In clean body builders only T4 and TSH were affected.</description><identifier>ISSN: 0960-0760</identifier><identifier>EISSN: 1879-1220</identifier><identifier>DOI: 10.1016/j.jsbmb.2015.03.003</identifier><identifier>PMID: 25797375</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Amides - pharmacology ; Anabolic Agents - pharmacology ; Anabolic steroids ; Androstenedione - pharmacology ; Aniline Compounds - pharmacology ; Animals ; Estradiol - blood ; Estrenes - pharmacology ; Follicle Stimulating Hormone - blood ; Gonadotropin-Releasing Hormone - blood ; Humans ; Hydrocortisone - blood ; Hypothalamic–pituitary–gonadal axis ; Hypothalamo-Hypophyseal System - drug effects ; Hypothalamo-Hypophyseal System - metabolism ; Inhibins - blood ; Injections, Subcutaneous ; Insulin-Like Growth Factor I - metabolism ; Luteinizing Hormone - blood ; Male ; Methandrostenolone - pharmacology ; Motor Activity ; Muscle Fibers, Skeletal - drug effects ; Muscle Fibers, Skeletal - metabolism ; Pituitary-Adrenal System - drug effects ; Pituitary-Adrenal System - metabolism ; Prolactin - blood ; Rats ; Rats, Wistar ; SARMs ; Testis - drug effects ; Testis - metabolism ; Testosterone - blood ; Thyroxine - blood ; Training</subject><ispartof>The Journal of steroid biochemistry and molecular biology, 2015-06, Vol.150, p.86-96</ispartof><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-1366f0172e7d70b32fbec86d746a69882ce08398d559fec9027325b0a052ad8a3</citedby><cites>FETCH-LOGICAL-c359t-1366f0172e7d70b32fbec86d746a69882ce08398d559fec9027325b0a052ad8a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jsbmb.2015.03.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25797375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hengevoss, Jonas</creatorcontrib><creatorcontrib>Piechotta, Marion</creatorcontrib><creatorcontrib>Müller, Dennis</creatorcontrib><creatorcontrib>Hanft, Fabian</creatorcontrib><creatorcontrib>Parr, Maria Kristina</creatorcontrib><creatorcontrib>Schänzer, Wilhelm</creatorcontrib><creatorcontrib>Diel, Patrick</creatorcontrib><title>Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis</title><title>The Journal of steroid biochemistry and molecular biology</title><addtitle>J Steroid Biochem Mol Biol</addtitle><description>•Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle mass in intact male rats.
Analysing effects of pharmaceutical substances and training on feedback mechanisms of the hypothalamic–pituitary–gonadal axis may be helpful to quantify the benefit of strategies preventing loss of muscle mass, and in the fight against doping. In this study we analysed combined effects of anabolic steroids and training on the hypothalamic–pituitary–gonadal axis. Therefore intact male Wistar rats were dose-dependently treated with metandienone, estradienedione and the selective androgen receptor modulator (SARM) S-1. In serum cortisol, testosterone, 17β-estradiol (E2), prolactin, inhibin B, follicle-stimulating hormone (FSH), luteinizing hormone (LH), Insulin-like growth factor 1 (IGF-1), and thyroxine (T4) concentrations were determined. Six human volunteers were single treated with 1-androstenedione. In addition abusing and clean body builders were analysed. Serum concentrations of inhibin B, IGF-1, cortisol, prolactin, T4, thyroid-stimulating hormone (TSH), testosterone and LH were determined. In rats, administration of metandienone, estradienedione and S-1 resulted in an increase of muscle fiber diameter. Metandienone and estradienedione but not S-1 administration significantly decreases LH and inhibin B serum concentration. Administration of estradienedione resulted in an increase of E2 and S-1 in an increase of cortisol. Single administration of 1-androstenedione in humans decreased cortisol and inhibin B serum concentrations. LH was not affected. In abusing body builders a significantly decrease of LH, TSH and inhibin B and an increase of prolactin, IGF-1 and T4 was detected. In clean body builders only T4 and TSH were affected.</description><subject>Amides - pharmacology</subject><subject>Anabolic Agents - pharmacology</subject><subject>Anabolic steroids</subject><subject>Androstenedione - pharmacology</subject><subject>Aniline Compounds - pharmacology</subject><subject>Animals</subject><subject>Estradiol - blood</subject><subject>Estrenes - pharmacology</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Gonadotropin-Releasing Hormone - blood</subject><subject>Humans</subject><subject>Hydrocortisone - blood</subject><subject>Hypothalamic–pituitary–gonadal axis</subject><subject>Hypothalamo-Hypophyseal System - drug effects</subject><subject>Hypothalamo-Hypophyseal System - metabolism</subject><subject>Inhibins - blood</subject><subject>Injections, Subcutaneous</subject><subject>Insulin-Like Growth Factor I - metabolism</subject><subject>Luteinizing Hormone - blood</subject><subject>Male</subject><subject>Methandrostenolone - pharmacology</subject><subject>Motor Activity</subject><subject>Muscle Fibers, Skeletal - drug effects</subject><subject>Muscle Fibers, Skeletal - metabolism</subject><subject>Pituitary-Adrenal System - drug effects</subject><subject>Pituitary-Adrenal System - metabolism</subject><subject>Prolactin - blood</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>SARMs</subject><subject>Testis - drug effects</subject><subject>Testis - metabolism</subject><subject>Testosterone - blood</subject><subject>Thyroxine - blood</subject><subject>Training</subject><issn>0960-0760</issn><issn>1879-1220</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kL2O1DAQgC0E4vYWngAJuaRJGNsb2yko0OrgkE6igdpy7MmtV0kcYu-J7XgH3pAnwWEPSqoZab75-wh5xaBmwOTbY31M3djVHFhTg6gBxBOyYVq1FeMcnpINtBIqUBKuyHVKRyiEYOo5ueKNapVQzYakfRy7MKGn2PfocqKxp3byS7zHqSS2i0NwNGVcYvBpLdH5cE7B2YFal8NDyGcaJ5oPSA_nOeaDHewY3K8fP-eQTyHb5Vzy-zhZv7Z8D-kFedbbIeHLx7glXz_cfNnfVnefP37av7-rnGjaXDEhZQ9McVReQSd436HT0qudtLLVmjsELVrtm6Ytp7fAleBNBxYabr22YkveXObOS_x2wpTNGJLDYbATxlMyTGpg7U6rXUHFBXVLTGnB3sxLGMvphoFZbZuj-WPbrLYNCLO63JLXjwtO3Yj-X89fvQV4dwGwvPkQcDHJBZwc-rAU2cbH8N8FvwG_9JVP</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Hengevoss, Jonas</creator><creator>Piechotta, Marion</creator><creator>Müller, Dennis</creator><creator>Hanft, Fabian</creator><creator>Parr, Maria Kristina</creator><creator>Schänzer, Wilhelm</creator><creator>Diel, Patrick</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201506</creationdate><title>Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis</title><author>Hengevoss, Jonas ; Piechotta, Marion ; Müller, Dennis ; Hanft, Fabian ; Parr, Maria Kristina ; Schänzer, Wilhelm ; Diel, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-1366f0172e7d70b32fbec86d746a69882ce08398d559fec9027325b0a052ad8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Amides - pharmacology</topic><topic>Anabolic Agents - pharmacology</topic><topic>Anabolic steroids</topic><topic>Androstenedione - pharmacology</topic><topic>Aniline Compounds - pharmacology</topic><topic>Animals</topic><topic>Estradiol - blood</topic><topic>Estrenes - pharmacology</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Gonadotropin-Releasing Hormone - blood</topic><topic>Humans</topic><topic>Hydrocortisone - blood</topic><topic>Hypothalamic–pituitary–gonadal axis</topic><topic>Hypothalamo-Hypophyseal System - drug effects</topic><topic>Hypothalamo-Hypophyseal System - metabolism</topic><topic>Inhibins - blood</topic><topic>Injections, Subcutaneous</topic><topic>Insulin-Like Growth Factor I - metabolism</topic><topic>Luteinizing Hormone - blood</topic><topic>Male</topic><topic>Methandrostenolone - pharmacology</topic><topic>Motor Activity</topic><topic>Muscle Fibers, Skeletal - drug effects</topic><topic>Muscle Fibers, Skeletal - metabolism</topic><topic>Pituitary-Adrenal System - drug effects</topic><topic>Pituitary-Adrenal System - metabolism</topic><topic>Prolactin - blood</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>SARMs</topic><topic>Testis - drug effects</topic><topic>Testis - metabolism</topic><topic>Testosterone - blood</topic><topic>Thyroxine - blood</topic><topic>Training</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hengevoss, Jonas</creatorcontrib><creatorcontrib>Piechotta, Marion</creatorcontrib><creatorcontrib>Müller, Dennis</creatorcontrib><creatorcontrib>Hanft, Fabian</creatorcontrib><creatorcontrib>Parr, Maria Kristina</creatorcontrib><creatorcontrib>Schänzer, Wilhelm</creatorcontrib><creatorcontrib>Diel, Patrick</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of steroid biochemistry and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hengevoss, Jonas</au><au>Piechotta, Marion</au><au>Müller, Dennis</au><au>Hanft, Fabian</au><au>Parr, Maria Kristina</au><au>Schänzer, Wilhelm</au><au>Diel, Patrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis</atitle><jtitle>The Journal of steroid biochemistry and molecular biology</jtitle><addtitle>J Steroid Biochem Mol Biol</addtitle><date>2015-06</date><risdate>2015</risdate><volume>150</volume><spage>86</spage><epage>96</epage><pages>86-96</pages><issn>0960-0760</issn><eissn>1879-1220</eissn><abstract>•Distinction of training/doping effects by hormone analytics in male humans possible.•Inhibin B is a sensitive marker for of anabolic substances uptake in male humans.•Anabolic steroids and SARM S-1 decrease prostate weight in intact male rats.•Anabolic steroids and SARM S-1 increase skeletal muscle mass in intact male rats.
Analysing effects of pharmaceutical substances and training on feedback mechanisms of the hypothalamic–pituitary–gonadal axis may be helpful to quantify the benefit of strategies preventing loss of muscle mass, and in the fight against doping. In this study we analysed combined effects of anabolic steroids and training on the hypothalamic–pituitary–gonadal axis. Therefore intact male Wistar rats were dose-dependently treated with metandienone, estradienedione and the selective androgen receptor modulator (SARM) S-1. In serum cortisol, testosterone, 17β-estradiol (E2), prolactin, inhibin B, follicle-stimulating hormone (FSH), luteinizing hormone (LH), Insulin-like growth factor 1 (IGF-1), and thyroxine (T4) concentrations were determined. Six human volunteers were single treated with 1-androstenedione. In addition abusing and clean body builders were analysed. Serum concentrations of inhibin B, IGF-1, cortisol, prolactin, T4, thyroid-stimulating hormone (TSH), testosterone and LH were determined. In rats, administration of metandienone, estradienedione and S-1 resulted in an increase of muscle fiber diameter. Metandienone and estradienedione but not S-1 administration significantly decreases LH and inhibin B serum concentration. Administration of estradienedione resulted in an increase of E2 and S-1 in an increase of cortisol. Single administration of 1-androstenedione in humans decreased cortisol and inhibin B serum concentrations. LH was not affected. In abusing body builders a significantly decrease of LH, TSH and inhibin B and an increase of prolactin, IGF-1 and T4 was detected. In clean body builders only T4 and TSH were affected.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25797375</pmid><doi>10.1016/j.jsbmb.2015.03.003</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-0760 |
ispartof | The Journal of steroid biochemistry and molecular biology, 2015-06, Vol.150, p.86-96 |
issn | 0960-0760 1879-1220 |
language | eng |
recordid | cdi_proquest_miscellaneous_1680194874 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Amides - pharmacology Anabolic Agents - pharmacology Anabolic steroids Androstenedione - pharmacology Aniline Compounds - pharmacology Animals Estradiol - blood Estrenes - pharmacology Follicle Stimulating Hormone - blood Gonadotropin-Releasing Hormone - blood Humans Hydrocortisone - blood Hypothalamic–pituitary–gonadal axis Hypothalamo-Hypophyseal System - drug effects Hypothalamo-Hypophyseal System - metabolism Inhibins - blood Injections, Subcutaneous Insulin-Like Growth Factor I - metabolism Luteinizing Hormone - blood Male Methandrostenolone - pharmacology Motor Activity Muscle Fibers, Skeletal - drug effects Muscle Fibers, Skeletal - metabolism Pituitary-Adrenal System - drug effects Pituitary-Adrenal System - metabolism Prolactin - blood Rats Rats, Wistar SARMs Testis - drug effects Testis - metabolism Testosterone - blood Thyroxine - blood Training |
title | Combined effects of androgen anabolic steroids and physical activity on the hypothalamic–pituitary–gonadal axis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T07%3A53%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20effects%20of%20androgen%20anabolic%20steroids%20and%20physical%20activity%20on%20the%20hypothalamic%E2%80%93pituitary%E2%80%93gonadal%20axis&rft.jtitle=The%20Journal%20of%20steroid%20biochemistry%20and%20molecular%20biology&rft.au=Hengevoss,%20Jonas&rft.date=2015-06&rft.volume=150&rft.spage=86&rft.epage=96&rft.pages=86-96&rft.issn=0960-0760&rft.eissn=1879-1220&rft_id=info:doi/10.1016/j.jsbmb.2015.03.003&rft_dat=%3Cproquest_cross%3E1680194874%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1680194874&rft_id=info:pmid/25797375&rft_els_id=S0960076015000886&rfr_iscdi=true |